MX9205852A - PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN

Info

Publication number: MX9205852A
Authority: MX; Mexico
Prior art keywords: calcitonin; pharmaceutical compositions; compositions containing; pharmaceutical; compositions
Prior art date: 1991-10-11

Application number

MX9205852A

Other languages

Spanish (es)

Inventor

Laura Chiodini

Teodoro Fonio

Mario Pinza

Original Assignee

Smithkline Beecham Farma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-11

Filing date

1992-10-09

Publication date

1993-06-01

1992-10-09 Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma

1993-06-01 Publication of MX9205852A publication Critical patent/MX9205852A/en

Links

102000055006 Calcitonin Human genes 0.000 title 1
108060001064 Calcitonin Proteins 0.000 title 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
229960004015 calcitonin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

MX9205852A 1991-10-11 1992-10-09 PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN MX9205852A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI912703A IT1251685B (en)	1991-10-11	1991-10-11	PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN

Publications (1)

Publication Number	Publication Date
MX9205852A true MX9205852A (en)	1993-06-01

Family

ID=11360856

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9205852A MX9205852A (en)	1991-10-11	1992-10-09	PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN

Country Status (9)

Country	Link
EP (1)	EP0607229A1 (en)
JP (1)	JPH07500099A (en)
AU (1)	AU2683492A (en)
BR (1)	BR9206707A (en)
CA (1)	CA2120755A1 (en)
IT (1)	IT1251685B (en)
MX (1)	MX9205852A (en)
PT (1)	PT100946A (en)
WO (1)	WO1993006854A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2285921A (en) *	1994-01-31	1995-08-02	Leilani Lea	Sublingual administration of medicaments
DE726075T1 (en) *	1995-02-08	1996-12-12	Therapicon Srl	Non-inorganic pharmaceutical saline solutions for endonasal administration
AU1808897A (en) *	1995-12-13	1997-07-03	Dullatur Limited	A calcitonin preparation
IT1294191B1 (en) *	1997-09-05	1999-03-22	Alfa Wassermann Spa	Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution
GB2368792A (en)	2000-10-06	2002-05-15	Roger Randal Charles New	Absorption enhancers
ITRM20010048A1 (en) *	2001-01-30	2002-07-30	Gregorio Mauro De	METHOD FOR PREPARING PHYSIOLOGICALLY ACCEPTABLE AQUEOUS SOLUTIONS SO OBTAINED.
GB0308732D0 (en) *	2003-04-15	2003-05-21	Axcess Ltd	Absorption enhancers
GB0308734D0 (en)	2003-04-15	2003-05-21	Axcess Ltd	Uptake of macromolecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60188315A (en) *	1984-03-07	1985-09-25	Yamanouchi Pharmaceut Co Ltd	Antipruritic plaster containing glycyrretic acid
JPS61267528A (en) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	Transnasal calcitonin agent containing absorbefacient
DE3887494T2 (en) *	1987-11-13	1994-05-19	Smithkline Beecham Farma	Medicines containing a calcitonin and a glycyrrhizinate as absorption promoter.
JPH078806B2 (en) *	1990-08-16	1995-02-01	旭化成工業株式会社	Nasal emulsion containing calcitonin

1991
- 1991-10-11 IT ITMI912703A patent/IT1251685B/en active IP Right Grant
1992
- 1992-10-08 CA CA002120755A patent/CA2120755A1/en not_active Abandoned
- 1992-10-08 EP EP92920956A patent/EP0607229A1/en not_active Withdrawn
- 1992-10-08 JP JP5506629A patent/JPH07500099A/en active Pending
- 1992-10-08 BR BR9206707A patent/BR9206707A/en not_active Application Discontinuation
- 1992-10-08 WO PCT/EP1992/002321 patent/WO1993006854A1/en not_active Application Discontinuation
- 1992-10-08 AU AU26834/92A patent/AU2683492A/en not_active Abandoned
- 1992-10-09 PT PT100946A patent/PT100946A/en not_active Application Discontinuation
- 1992-10-09 MX MX9205852A patent/MX9205852A/en unknown

Also Published As

Publication number	Publication date
EP0607229A1 (en)	1994-07-27
ITMI912703A1 (en)	1993-04-11
JPH07500099A (en)	1995-01-05
BR9206707A (en)	1995-10-31
AU2683492A (en)	1993-05-03
CA2120755A1 (en)	1993-04-15
IT1251685B (en)	1995-05-19
WO1993006854A1 (en)	1993-04-15
PT100946A (en)	1993-10-29
ITMI912703A0 (en)	1991-10-11

Publication	Publication Date	Title
ITMI922400A0 (en)	1992-10-20	PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
MX9203236A (en)	1992-12-01	PHARMACEUTICAL COMPOSITION THAT INCLUDES A CYCLOSPORINE.
FI981777A0 (en)	1998-08-18	Pharmaceutical composition
DE4291156T1 (en)	1994-10-20	Improved pharmaceutical compositions
PT589843E (en)	2002-04-29	PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
DE69230893D1 (en)	2000-05-11	Dental packaging unit
ATE203400T1 (en)	2001-08-15	PHARMACEUTICAL FORMULATIONS
NO306602B1 (en)	1999-11-29	Powder Dispenser
NO923127D0 (en)	1992-08-11	PHARMACEUTICAL COMBINATION FORM
DE69207355D1 (en)	1996-02-15	Childproof blister
BR9200058A (en)	1992-09-08	PHARMACEUTICAL COMPOUND AND COMPOSITION
DE69233258D1 (en)	2004-01-08	powder dispenser
ATA240692A (en)	1996-02-15	PHARMACEUTICAL COMPOSITIONS CONTAINING RANITIDE INISMUTCITRATE
ITMI921123A0 (en)	1992-05-11	ORAL PHARMACEUTICAL FORMULATIONS CONTAINING ANTHOCYANOSIDS
MX9200622A (en)	1992-11-01	PHARMACEUTICAL COMPOSITION
ITMI922230A0 (en)	1992-09-28	COSMETIC COMPOSITIONS CONTAINING A POLYETHOXYLATED VITAMIN E
MX9205852A (en)	1993-06-01	PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
IT8620865A0 (en)	1986-06-20	PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN.
ITMI922885A1 (en)	1994-06-18	CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING NICERGOLINE
ATA66889A (en)	2002-01-15	SEALED MULTIPLE DOSE DISPENSER
IL99867A0 (en)	1992-08-18	Pharmaceutical compositions containing activin a
IL103226A0 (en)	1993-02-21	Pharmaceutical compositions containing calcitonin
DK136492D0 (en)	1992-11-10	A PHARMACEUTICAL FORMULATION
MX9204164A (en)	1993-05-01	PHARMACEUTICAL COMPOSITION THAT INCLUDES ARNDH.
ITMI912766A1 (en)	1993-01-19	PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN